Stay updated with breaking news from Phyllis Arthur. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Even with the historic effort to develop COVID-19 vaccines, drug makers developing new vaccines for infectious diseases received 3.4 percent of all venture capital raised for biopharma companies in the past 10 years, according to a BIO report.
We’ve known the dangers of antimicrobial resistance for years. What if we used what we learned from covid to tackle it?
One program covers nearly three times as many vaccines today as it did when it was created three decades ago. Despite bipartisan calls for change, Congress has failed to act.
We asked our top-notch reporters to share what their biggest takeaways were from the day and what it was like to participate.
There’s reportedly an agreement on a COVID-19 vaccine IP waiver – here's what we know so far. Also, we recap yesterday’s mark-up of a pandemic preparedness bill and look ahead to two agriculture hearings today. (984 words, 4 minutes, 55 seconds) P.S. Early-bird registration for the BIO International Convention ends…